CureAccelerator Live! for Rare Diseases 2021

CureAccelerator Live! for Rare Diseases – with a focus in 2021 on Pediatrics


Virtual: main event June 10, 2021 from 4:30pm ET to 6pm ET; winner announced June 11, 2021. 

CureAccelerator Live! is our philanthropic pitch event where up to 5 PIs are the finalists presenting their clinical repurposing trials for up to $50,000 in funding and attendees select the winning project.


Joyce Teng, MD, PhD representing

Stanford University logo

Treating Vascular Malformations in the Face, Head and Neck Using Trametinib

Joyce Teng headshot

Nancy Gordon, MD representing

MD Anderson Children's Cancer Hospital

Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine

Nancy Gordon



Joseph Rower, PhD representing

University of Utah logo

Repurposing Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss

Ignacia Fuentes, PhD representing

DEBRA Chile logo

Repurposing a Common Antioxidant Nutraceutical, N-Acetylcysteine, for Wound Treatment in Butterfly Skin

Ignacia Fuentes headshot

CureAccelerator Live! for Rare Diseases 2021 is part of the virtual

RARE Drug Development Symposium - virtual

on June 9 – 11, 2021, in partnership with

Global Genes

Click here for more information!


The RARE Drug Development Symposium is a partnership between Global Genes and the Orphan Disease Center of the University of Pennsylvania.

U Penn Orphan Disease Center - 10 year

Cures Within Reach is proud to hold this event in support of our Rare Diseases Community.


In addition, we are grateful to our philanthropic partner for its support:

Charles H Hood Foundation Logo


Questions? Email Director of Scientific Affairs: Dr. Clare Thibodeaux at